4.88
7.49%
+0.34
(Pre-market:
4.98
+0.1000
+2.05%)
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Kennedy Brendan | Director | Aug 05 | Sale | 14.46 | 300,000 | 4,338,570 | 7,974,196 |
Kennedy Brendan | Director | Aug 04 | Sale | 14.08 | 300,000 | 4,224,270 | 8,274,196 |
Kennedy Brendan | Director | Jul 16 | Sale | 14.04 | 300,000 | 4,211,430 | 8,574,196 |
Kennedy Brendan | Director | Jul 15 | Sale | 14.67 | 300,000 | 4,400,838 | 8,874,196 |
Kennedy Brendan | Director | Jun 18 | Sale | 17.19 | 400,000 | 6,874,040 | 9,174,196 |
Kennedy Brendan | Director | Jun 17 | Sale | 17.97 | 400,000 | 7,186,640 | 9,574,196 |
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.
List of SPAC Stocks
List of EV Stocks and Related Stocks
Top 100 popular stocks on Robinhood
List of Marijuana Stocks
Cap:
|
Volume (24h):